Novartis India Ltd

NSE: NOVARTIND BSE: 500672

₹2046.80

(1.70%)

Thu, 24 Sept 2026, 06:06 pm

MTF 5xInvest in Novartis India Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)5137.78

PE Ratio51.69

Dividend1.20

Health Technology

Pharmaceuticals: Major

24.5K

Novartis India News

Novartis India AGM approves ESOP 2026 and director appointments

Novartis India Limited held its 78th AGM, approving ESOP 2026 and regularizing appointments for seven directors. The meeting also ratified the appointment of Dr. Vikas Gupta as MD & CEO.

24 Sept 2026

companies

Novartis India to host investor meet on Sep 28

Novartis India Limited will participate in the Nuvama Emerging India CEO Forum in Mumbai on September 28, 2026. The company confirmed no unpublished price sensitive information will be disclosed during the meetings.

23 Sept 2026

companies

Novartis India unveils growth strategy

Novartis India plans to double revenue in four years via M&A and organic growth. The company acquired Pfizer's Minipress XL trademark and in-licensed ophthalmology assets.

15 Sept 2026

companies

Novartis India to host investor call on Sep 11

Novartis India Limited will hold an analyst and institutional investor meeting on September 11, 2026. The virtual and physical event in Mumbai will cover publicly available information only.

08 Sept 2026

companies

Novartis India Board Reconstituted After ChrysCapital Takeover

Novartis India's board was reconstituted on July 29, 2026, with six new directors appointed and six outgoing directors resigning following ChrysCapital's acquisition of control from Novartis AG.

29 Jul 2026

companies

Showing 1–5 of 44

Rows per page:

Market Current News

RBI Deputy Gupta sees rupee strengthening potential

RBI Deputy Governor Gupta has expressed confidence that the rupee has good potential to strengthen from its current position, signalling a constructive outlook on the currency.

23 Sept 2026

currency

SRIT India IPO: ₹1,204 Cr Order Book; Rev CAGR 28.8%

SRIT India Limited files DRHP for an IT/ITeS IPO. The Bengaluru-based firm reports a 28.84% revenue CAGR and a ₹1,204.72 crore order book as of June 2026.

23 Sept 2026

ipo

Shah Investors Home IPO: ₹60 Cr Fresh Issue

Gujarat-based broker Shah Investors Home Ltd files DRHP for ₹60 crore fresh issue. FY2026 revenue at ₹71.48 Cr; PAT declined to ₹13.11 Cr.

23 Sept 2026

ipo

Jaykay Enterprises Limited

Jaykay Enterprises promoter group oversubscribes rights issue

Jaykay Enterprises Ltd reports promoter group oversubscription of 19.45 lakh shares in ongoing rights issue, offsetting non-subscription by some members.

23 Sept 2026

ipo

S K Offset IPO Day 1: Subscribed 0.11x

S K Offset IPO sees muted response on Day 1 with overall subscription at 0.11x. QIBs subscribed 0.50x, while retail demand remained negligible at 0.01x.

23 Sept 2026

ipo

Showing 1–5 of 94365

Rows per page: